Amedisys AMED
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Business overview of Amedisys (AMED)
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
Key Insights
Critical company metrics and information
Latest Closing Price
$92.37Market Cap
$3.03 BillionPrice-Earnings Ratio
69.98Total Outstanding Shares
32.81 Million SharesTotal Employees
19,000Dividend
No dividendIPO Date
August 17, 1994SIC Description
Services-home Health Care ServicesPrimary Exchange
NASDAQType
Common StockHeadquarters
3854 american way, Baton rouge, LA, 70816Homepage
https://www.amedisys.com
Historical Stock Splits
If you bought 1 share of AMED before December 5, 2006, you'd have 1.33 shares today.
| Execution Date | Split Amount |
|---|---|
| December 5, 2006 | 4-for-3 |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $164.38 Million |
| Net Cash Flow From Operating Activities, Continuing | $221.66 Million |
| Net Cash Flow From Investing Activities | $-8.36 Million |
| Net Cash Flow From Investing Activities, Continuing | $-8.36 Million |
| Net Cash Flow From Operating Activities | $221.66 Million |
| Net Cash Flow | $164.38 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Operating Income/Loss | $94.54 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $-5.07 Million |
| Income Tax Expense/Benefit, Deferred | $7.42 Million |
| Benefits Costs and Expenses | $2.26 Billion |
| Depreciation and Amortization | $18.00 Million |
| Gross Profit | $1.02 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $43.23 Million |
| Comprehensive Income/Loss | $38.16 Million |
| Other Comprehensive Income/Loss | $0 |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $-5.07 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Accounts Payable | $39.96 Million |
| Other Non-current Assets | $1.38 Billion |
| Assets | $2.14 Billion |
| Other Current Liabilities | $322.44 Million |
| Long-term Debt | $377.30 Million |
| Prepaid Expenses | $13.07 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Recent Headlines From The Web
Latest news, press releases, and media coverage about AMED from trusted financial sources
ⓒ 2025 Financhle. All Rights Reserved.